MEMBER LOG-IN

LOGIN HELP

LogIn Help

SIGN UP

CLICK TO CREATE AN ACCOUNT
JOIN US or FOLLOW US HERE go to linkedIn go to twitter

New Account Registration

Yes No

Please sign me up for these other regions too:

BIO Europe BioBreak
New Jersey BioBreak
Philly BioBreak
Utah BioBreak
JPMorgan BioBreak
Boston BioBreak
UK BioBreak
Big BIO BioBreak
New York BioBreak
Sweden BioBreak
All Regions
Yes No
I agree with BioBreak's Privacy Policy

Refer a Friend

Reset Password

JPMorgan BioBreak – Events Archive

Please see below for attendees and images from this event.

JPMorgan JPMorgan BioBreak January 7, 2018 5:30-8:00 pm

Co-Hosts for this event

Name Company
(No co-hosts found)

Attendees at this event

Geoff Meyerson Locust Walk
Mahmoud Mahmoudian Boston BioMedical
Jamil Beg 5AM Ventures
Scott Shandler Longevity Biotech
Warren Cooper HealthCare Royalty Partners
Benjamin Doranz Integral Molecular
Keith Goldan Optinose
Deborah Harland SR One
Jim Lewis Personal Genome Diagnostics
Dean Miller Novitas Capital
Jay Mohr Dirigo Therapeutics
Richard Morris Context Therapeutics
Rifat Pamukcu Midway Pharmaceuticals
Michael Saporito Intervir
Kevin Taylor Nabriva Therapeutics
Asish Xavier Johnson & Johnson Innovation
Shawn O'Brien KEY BIOPHARMA
Harry Atkins Incyte Corporation
Kathleen McGowan Palvella Therapeutics, Inc.
Brian McVeigh Zafgen
Matt Handel ExpressCells
Sarabjit Ashta Glycadia Pharma
Jordan Leef Pyramid Biosciences Inc
Joan Lau Militia Hill Ventures
Rachel Cervantes Synthetic Genomics
Terri Sebree Zynerba Pharmaceuticals
Mehul Shah Pfizer
Roberto Cuca Trevena
J. David Owens BiologicsMD, Inc
Nate Massari AmerisourceBergen
Martin Lehr Context Therapeutics
Scott Megaffin Mirata Pharmaceuticals
Michael King PDS Biotechnology
Jeremy Goldberg JPG Healthcare LLC
Morgan Conn CallisBio
Chris Slavinsky Pfizer
Mark Suseck Seqirus
Donald Fishbein Evolve Therapeutics
Daniel Kennedy GlaxoSmithKline
Imran Eba Action Potential Venture Capital
Tauseef Butt Progenra
Keith Marmer University of Utah
Jeff Behrens Siamab Therapeutics
Christopher Schaber Soligenix
Jason Walsh Provenance Biopharmaceuticals
Cameron Durrant Taran
Brad Prosek Constellation Pharmaceuticals
Marc Schwabish Eisai
Catherine Thut Novartis Institutes for BioMedical Research
Ryan Brady Evotec
Bonnie Fendrock Cyta Therapeutics
Brad Carver SynDevRx
Phil McGurk Pfizer
Rick Lundberg Navitor Pharmaceuticals
Adam Muzikant Flexion Therapeutics
Dan Koerwer Arrakis Therapeutics
Derek Brand Quicksilver Biosystems
Michal Preminger Harvard University
Bibhash Mukhopadhyay New Enterprise Associates
Thomas Luby Johnson & Johnson Innovation, JLABS
Kathryn Gregory Seneb BioSciences, Inc.
Dora Mitchell Carisma Therapeutics Inc.
Heather Rose Thomas Jefferson University
Caleb Winder Excel Venture
Patrick Walsh Akebia Therapeutics
Nancy Wetherbee Tufts Medical Center
Avi Spier Novartis
Arthur Hiller Antyllus Therapeutics
Oren Gilad Atrin Pharmaceuticals
Anjan Aralihalli Glypharma
Guangtao Zhang Eleison Pharma
Harish Krishnaswamy Macrogenics
Scott Edwards SciFluor Life Sciences
Richard Kollender Quaker Partners
Guy Fish Fletcher Spaght
Richard Kivel GrayBella Capital
Rob Sterling Ichor Therapeutics
Paul Barone Inspirion Pharmaceuticals
Helen Ho Blueprint Medicines
Martin Phillips Opsidio
Agnieszka Czechowicz Stanford University
Dawn Eringis Integral Molecular
Tania Dimitrova Pfizer
Douglas Fisher InterWest Partners
Andy Meyerson Locust Walk
Kuldeep Neote J&J Innovation Center-Boston
Brendan Downey Takeda
Kumar Bhargava Serentrix
Jane Hollingsworth Militia Hill Ventures
Sundeep Dugar Sphaera Pharma
Kees Been Lysosomal Therapeutics
John Hallinan MassBio
Catherine Abbadie Sunovion
Minji Kim Jounce
Manohar Katakam Sterotherapeutics LLC
Joseph Zack Excalivir Diagnostics
Ramani Varanasi X-Biotix Therapeutics, Inc.
John Delyani Tmunity
Tariq Kassum Obsidian
Gwen Melincoff Gemini Advisors LLC
Neil Swami MVM Life Sciences Partners
Chris Baird Locust Walk
Martin Heidecker Boehringer Ingelheim Venture Fund
Jeffrey Moore MP Healthcare Venture Management
Maria Maccecchini QR Pharma
Rachel Loui Boehringer Ingelheim
Margie McGlynn IAVI
Thomas Hofmann Aumapharma
James Shanahan SynDevRx, Inc.
Colin Hill GNS Healthcare
Alexander Pickett Mediqventures, Ltd.
Christian Suojanen Bioseed Capital
Jennifer King Intellia Therapeutics
Iya Khalil GNS Healthcare
Josh Hamermesh Gamida Cell
Catherine Sohn Jazz Pharmaceuticals
Bernard Rudnick Atrin Pharma
Wendy Liu Pfizer
Adele Gulfo Mylan
Lew Bender Intensity Therapeutics
Ryan Cochran New Leaf Venture Partners
Erik Lium Mount Sinai Health System
Alan Roemer Roivant Sciences
Jerry Jabbour Matinas BioPharma
Bruce Goldsmith Lycera
Tom Hallam Leading BioSciences
Samuel Helfaer Athyrium
Lizabeth Leveille Merck
Eric Mortensen CytoSorbents Inc.
Geert Cauwenbergh RXi Pharmaceuticals
Eric Nelson Fannin Innovation Studio
Ailis Tweed-Kent Cocoon Biotech
Walter Kowtoniuk Third Rock Ventures
Walter Olesiak Remiges Ventures
Scott Morenstein CAM Capital
Alan Wills CSL Behring
Maude Tessier Kyn Therapeutics
Amanda Cashin Illumina
Michael Shih Sanofi
Jennifer Laux Inovio Pharmaceuticals
Stephen Potter AGTC
Felipe Araujo Mount Sinai Innovation Partners (MSIP)
Mark Stencik Merck
Carol Ashe New York Genome Center
Ravi Rao Vtesse
Michael Batten JDRF T1D Fund
Neal Farber NEUROHEALING PHARMACEUTICALS
Derek Yoon AJU IB Investment
Timothy Sullivan AJU IB Investment
Christopher Earl International AIDS Vaccine Initiative
Eric Zimmerman 6 Dimensions Capital
Imran Babar Venture Capital
Patrick Tricoli NANOBIOTIX US
Sourav Sinha Oncolinx
Christo Shalish Moderna
Peter Williams ImmunoGen, Inc.
Vicki Morgan viDA Therapeutics
Andrew meadow Excelyrate Capital
Mathias Woker Synovo GmbH (USA)
Kathie Jordan Drexel University
Brandi Simpson Navigen
John Krayacich Novartis
Kevin Chu F-Prime Capital Partners
Fumitaka Mori Remiges Ventures
Anna Christo MassBio
Girish Aakalu Ipsen
Duncan Hamish Wright Merck/MSD
Guillermo Rubio AMAG Pharmaceuticals
Bryan Stuart Yarra Therapeutics
Remis Bistras ThermoPharma
Jonathan Mandelbaum Accelerator Life Science Partners
Anna Turetsky Lightstone Ventures
Frank Walsh Ossianix
Lori Gavrin Tmunity
Wei Zhang Investor
James Glasheen Technology Partners
Rathin Das Synergys Biotherapeutics
Gordon Saul Stanford University
Stephen Curtis MPM Capital
Brett Fleshman Chiesi USA
Will Robberts TesoRx Pharma
Richard Brudnick Biogen
Rishi Gupta OrbiMed
Christine Brennan MRL Ventures Fund
Edgardo Baracchini Xencor
Jane Dancer F-star
Alok Ghosh NAYAderm
Sheila DeWitt DeuteRx
Timothy Trost Chimerix
Laura Hales Extend Biosciences Inc.
Anh Hoang Sofregen Medical
Jeffrey Wade Lexicon Pharmaceuticals
Wen Luo Denovo Biopharma
Gary Novack PharmaLogic Development
Joshua Rome Patagonia Pharmaceuticals, LLC
Zach Rome Patagonia Pharmaceuticals
Tanya Shnaydman Santen
Mark Jelley OrbiMed
Michael Hayden Teva Pharmaceutical
Gary Lee Amicus Therapeutics
Joe Whalen Horizon Pharma
Darren Braccia Lysosomal Therapeutics
Anthony Recupero Celsion Corporation
Anne Marie Robertson Ipsen
Glenn Larsen Aquinnah Pharmaceuticals
Linda Brown BioNJ
Naoya Sato MP Healthcare Venture Management
John Brooks Arete Worldwide
Ole Mikkelsen Accuray
Charles Link NewLink Genetics
John Freshley ONL Therapeutics
Stacey Seltzer Aisling Capital
Michael Garrett EnBiotix
Robert Beardsley Galera Therapeutics
Anil Goyal MimiVax, LLC
Martin Cearnal CumberlandPharmaceuticals
Adam Bruce TikoMed
Bob Linke Embera NeuroTherapeutics
Meredith Fisher Partners Innovation Fund
Peter Heinecke Ionetix
Koji Naito Mitsubishi Tanabe Pharma Corporation
Patrick Cheng Mount Sinai Innovation Partners
Takuro Wakabayashi ASTEC
Steve Engen Locust Walk
Doug Lee Samsung
Jeffrey Abbey Argos Therapeutics
Allen Ruszkowski CVAC Systems
Christina Dickerson Corium International
Bobby Sandage Euclises Pharmaceuticals
Jeff Peterson Target Discovery & Veritomyx
John Gregg Balinbac Therapeutics
Michael Klein Inflection Point
Philippe Douville Milestone Pharmaceuticals
David Larwood Valley Fever Solutions
Alex Shlyankevich Millhouse
Bruce Beutel SQZ Biotech
Eric Stone Velano Vascular
TR Thirucote TesoRx Pharma
Ming Fang Redmile
Jai Wall Sebela
Ian Li 1315 Capital
Jonas Ekblom Pergamum
Glenn Batchelder Alysium
Mark Reynolds GeoVax
Christian Kopfli Chromocell
Scott Platshon EcoR1 Capital
Beth Klein DuraThera
Michael Haller Denovo Biopharma
Brad Morgan POC Medical Systems
Lu Alleruzzo Immunophotonics
Jack Pasini Oligomerix
James Moe Oligomerix
Mary Ann Gray Gray Strategic Advisors
Danguole Altman Vapogenix
Michael Detke Embera NeuroTherapeutics
Hhilippe Mauberna Nanobiotix
Kollol Pal Pyramid Biosciences
Nail Edikhanov Klyss Biotech
Steven Bloom Verastem
Sara Nunez-Garcia Independent
Ashleigh Palmer Celimmune
Laurie Actman PCI
Roz Sweeney PDL Biopharma
Karen Boezi Broadway Angels
Ling Wong SLV
Douglas Kawahara Elex Biotech
Mario Alberto Accardi Orthonika
Rick Stewart Ricanto
Rhonda Bracey Channel Medsystems
Randy Rivera GC Finance
Laurent Levy Nanobiotix
Joe Pennino Pennino, LLC
Shahzad Malik Advent Life Sciences
Milenko Cicmil Merck
Carter Keller GigaGen
Elizabeth Aylward Seattle Children's Research Insitute
Michael Tippie TomegaVax, Inc.
Ping Guo The puguang investment holding group
Rakesh Marwah Palo Alto Investors
Timothy Considine Recursion Pharmaceuticals
Christopher Gibson Recursion Pharmaceuticals
Eric Singer Bradley Woods & Co
Sara Radcliffe California Life Sciences Association
Robert Little Denovobiopharma
Randy Preston Esculon Inc.
Jayson Punwani Takeda Ventures
Scott Weiner Pappas Ventures
Connor Duffy Reverie Labs
Mervyn Maze NeuroproteXeon
Michael Roy Mallinckrodt
Josh Schafer mallinckrodt
Sam Tetlow Grant Engine
Dennis McNamara Dualogics
David Soergel Novartis
Ivan Joseph Hsiri Therapeutics
Rodolphe Clerval ENTEROME
Lex Van der Ploeg DeuteRx
Jim Roach Pulmatrix
Brendan Luu EMD Serono Inc.
Matthew Hawryluk Gritstone Oncology
Kelly Bryant California Life Science Association (CLSA)
Stephen Yoder Pieris Pharmaceuticals, Inc.
Lawson Macartney Viking Therapeutics
Siddarth Subramony H.I.G. Capital
Joseph Vacca J. Vacca Consulting LLC
Benjamin Lewis The One Health Company
Peng Leong Novogen
John M Sorvillo ReForm Biologics
Elizabeth Wagner Constant Pharmaceuticals
Stefano Gulla Abcuro
Barbara Sosnowski Pfizer
Howard Kim Asahi Kasei
Maria Zlyhastseva BioBreak
Thomas Bliss Genisphere
Armin Rump Otsuka Pharmaceutical
Kirsten Leute Osage University Partners
Debra Travers PolyAurum, LLC
Rich Daly Neuralstem, Inc.
Craig Matturro 1315 Capital
Ben Cowen ImmunoMet Therapeutics
Scott Applebaum Context Therapeutics
Steven Gelone Nabriva Therapeutics
Neil Lineberry Takeda Pharmaceuticals
Kevin Pong Anima Biotech
Matthew Gantz Sobi
Chiraag Patel chimeron bio
Alan Ginsberg Shire
anne altmeyer self
Topher Brooke AstraZenca
Ram Aiyar Corvidia Therapeutics
Steve Carchedi Apexian Pharmaceuticals
Karen Krumeich Soligenix, Inc
Steve Axelrod G-Tech Medical, Inc.
Jung Choi Global Blood Therapeutics
Rashida Karmali Tactical Therapeutics, Inc
christophe degois Aimmune Therapeutics
Warren Czerniak Gedeon Richter USA
Michael McCully Terranova Bioventures
Virginie ALLIX VIRBAC
Bryan Lord Orthopedic Venture Partners
Jernej Godec Apple Tree Partners
Christopher Holterhoff Amicus Therapeutics
Gurpreet Ratra Spark Tx
Jessica Droge Amgen
David Parkinson Essa Pharmaceuticals Inc
Lisa McKerracher BioAxone Biosciences Inc.
Cathy He Highlight Capital
Peter Haberz MEI Pharma
Victoria Cameron Hercules Capital
Roberto Barzi Fort Rock Capital
Lawrence Klein CRISPR Therapeutics
William Korinek Astrocyte Pharmaceuticals
Michihito Onishi Locust Walk
Joseph Plevelich FEMME PHARMA
Shobha Parthasarathi Harrington Discovery Institute
Eric Soller Versant Ventures
James Manuso RespireRx Pharmaceuticals Inc.
Midori Yokoyama Jace Biomedical
Kayvon Pourmirzaie Nasseo
Michael Dudley TransCode Therapeutics, Inc.
Linda Hogan LLH Associates, LLC
Richard Hoyt Mallinckrodt
Kaveh Milaninia Multerra Bio
Bradley Everson HepQuant
Edward Kliphuis Merck Ventures
Mark Wilson MatriSys Bioscience
Takashi Noaki Santen Inc
Rodney Altman Spindletop Capital
Saeid Babaei BriaCell Therapeutics Corp.
Mukilan Mohan INanoBio Inc.
John nolan WBB Securities - Asset Management
Michael Nelson Intrommune Therapeutics
Chris Cain Apple Tree Partners
Erick Berglund Intrommune Therapeutics
Anthony Robinson Intrommune Therapeutics
John Oksinski NeuClone
Russell Howard NeuClone
Noelle Sunstrom NeuClone
Daniel Seto SternAegis Ventures
Shawn Marcell ReadCoor
Komal Joshi Jounce Therapeutics
Michael Ciesielski MimiVax, LLC
Angela Huang Presto Therapeutics
Anders Wiklund Wiklund International
Jacqueline Simon Reliefband Technologies
Scott Jenkins AlleCures
Sanjeev Redkar CBT Pharmaceuticals Inc.
Lei Shi Fidelity
Christopher Belnap Resilient Biotics, Inc
Shadi Saberi iSono Health
Erik Gentalen Intabio
William Altman CorInnova, Inc.
jim datin BioAgilytix
David Madden Mellitus LLC
Kenneth Kashkin K2/MABA/Chromocell
Norbert Prenzel Sotio
Lisa Placanica Mount SInai Innovation Partners
Brad Loncar Loncar Investments
Anne Vallerga AlleCures Inc
Stephen Lensky EpimAb Biotherapeutics
Avina Sun OceanIQ Capital
Tim Mitchell Sareum Ltd
Dan Brims Wolfswood Partners
Ruby Holder Roivant Sciences
Sam Assmann California Life Sciences Association
Marshall Hayward Jupiter Orphan Therapeutics
Kia Motesharei EMD Serono
Matthew Schiller EMD Serono
Ely Benaim Rexahn Pharmaceuticals
Michael Van Zandt ARC Institution
Larry Cai Fosun
Christopher Hanson Grant Park Ventures
Kousuke Nakata Kissei Pharmaceutical Co., Ltd.
Katsuyoshi Akiyama Kissei Pharmaceutical Co., Ltd.
Matthew De Silva Notable Labs
Lori Hu Vertex Ventures HC
Sukaina Alarakhia Moore Venture Partners
Simon Jones Regenacy Pharmaceuticals LLC
Thomas Farb-Horch Thrive Bioscience, Inc.
Raj Mohanty FemtoDx
Stephane Richard CureMatch Inc
Jason Ruth 5AM Ventures
Kathryn McCabe Eli Lilly
Nevin M. Summers MIT Synthetic Biology Center
Benjamin Sigel Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Laura Tadvalkar MP Healthcare Venture Management
Kerrie Brady Cetrexion Therapeutics
Marissa Fayer HERHealthEQ
Joseph Lobacki Crestovo LLC
Ramon Salsas Escat University of Pennsylvania, Gene Therapy Program
John Furey Spark Therapeutics
Arkesh Mehta OncoBindi Therapeutics
Joff Masukawa Diligentia
David Meininger Trianni, Inc.
Preston Noon Agent Capital
Richard Fitzgerald Sesen Bio, Inc.
Reza Mazhari Novartis Institutes for BioMedical Research
J. Christopher LiPuma Kastle Therapeutics
Maria Palasis 480 Biomedical, Inc.
Rachael Hagan NephroDI Therapeutics, Inc.
Anna French Qiming Venture US
Rosy Hu Partners Innovation Fund
Isabella Zhang JDRF T1D Fund
Melissa BradfordKlug Keryx
James Brauch Keryx Biopharmaceuticals
TIm Funnell
William Taylor Protalix Biotherapeutics
James Jogerst Berg Health
Melissa Epperly PsiOxus
Sunil Joshi Gradalis
Kathryn McAllister Merck
Fred Chereau LogicBio
Tom Wilton LogicBio
Joseph Driscoll Evol Science
Sarah Johnson Drexel University
Rakhshita Dhar Roche
Suresh Borsadia SHINKEI Therapeutics
Seiji Nakano Asahi Kasei - Healthcare
John Parker Springhood Ventures
Kyle Dempsey MVM Partners
Philipp von Gallwitz Locust Walk
Joanne Hackett Genomics England
Tom McCarthy Grey Wolf Therapeutics Ltd
Peter Joyce Grey Wolf Therapeutics
Frank Haluska BioCanCell
Jochen Kohlhaas Hummingbird Diagnostics GmbH
Bruce Cohen Xeraya Life Capital
Hayato Watanabe Eight Roads Ventures Japan
Raymond Houck Meraki Pharmaceuticals
Manfred Horst Biophytis
Sanjay Zaveri Strongbridge Bio
Eric Rhodes ERS Genomics Ltd
Michael Scherz Metys Pharmaceuticals AG
Grayson Allen LaunchPad Medical
Alex Zisson H.I.G. Capital
Carin Rollins Hinge Bio, Inc.
Brittany Berry-Pusey Avenda Health
Matthew Kinn Recursion Pharmaceuticals
Martin Brenner Recursion Pharmaceuticals
Al Altomari AGile Therapeutics, Inc.
Pamela Contag BioEclipse Therapeutics
Ambaw Bellete Photocure
Dominic Whang Locust Walk
Ed Mascioli EMMD LLC
Francisco Leon Provention
Koji Hirabata Locust Walk
John Chisholm Genomics England
Andrew Parker Zealand Pharma
Timothy Cooke NovaDigm Therapeutics
bridget lacey Circassia
Ichiro Nakatomi NanoCarrier Co., Ltd.
Tetsuhito Matsuyama NanoCarrier Co., Ltd.
Sonke Svenson NanoCarrier US
Mark Barrett Frazier Healthcare
Eric Risser MacroGenics Inc
Phillip Cox Capgenic Advisors
Ronald Martell Indapta
Clifford Stocks OncoResponse, Inc.
Joshua Zinns Botanic Properties
Amanda Hayward Velocity Pharmaceutical
Michael Barton Incintas Therapeutics, Inc.
Zack Scott Leerink Revelation Partners
Jason Mellad Cambridge Epigenetix
Rachel Dreilinger NeuraMedica
Neil Exter Third Rock Ventures
Marc Schwabish Fusion Pharma
Scott Coiante Agile Therapeutics
Elizabeth Garner Agile Therapeutics
Renee Selman Agile Therapeutics
Toshiyuki Mori NanoCarrier Co., Ltd.
jill jene twoXAR, Inc.
Margaret Hsiao Harvest moon pharma
dahai guo PuraCap Pharma
Kazuhiko KATO ASKA pharma
Takaharu Jibiki ASKA Pharmaceutical Co., Ltd.
Yogesh Bahl Bahl Partners
Raksha Shah Obsidio Therapeutics, Inc.
Yoshiaki Kato Kissei America Inc.
Masaya Etoh Asahi Kasei Pharma Corp
John Platts Ullyses Holdings
Christine Foster Acceleron Pharma
Steve Orndorff IM Therapeutics
Logan Snyder Ulysses Holdings
Errik Anderson Ulysses Holdings
Amanda Gett-Chaperot Seventure
Martin Tolar Alzheon
Michael Schrader Vaxess Technologies
Mark Saad Alethea Capital
miwa toyoda JAFCO Co., Ltd.
Claudio Rumazza Innogest Capital
Amber Salzman Adverum Biotechnologies, Inc.
Hemanshu Shah Transgene SA
Lee McCracken Drawbridge Health
Jerry Williamson KEW, Inc.
Randy Berholtz Mesa Verde Venture Partners
Aaron Schuchart Aeglea BioTherapeutics
Kyungjin Kim ST Pharm
David Moller Sigilon Therapeutics
Anthony Rapsomanikis HealthCare Royalty Partners
Navin Govind Aventyn, Inc
Darrell Sorenson VenSource Capital
Paul Jaminet Angiex Inc
Sheldon Ng Locust Walk
Jeongmin Kim Jeil Pharmaceutical
Sang Chul Han Jeil Pharmaceutical Co.,Ltd.
Tae Hoon Kim Aju Pharm
Patrik Sobocki Industrifonden
Jim Jogerst Berg, LLC
Sumit Jamuar GLOBAL GENE CORP
Brett Malone Flagship Biosciences
Geunjho Lim ST Pharm
Kris Choi ST Pharm
Hanseong Bang ST Pharm
Kushagra Sharma Global Gene Corp Pvt Ltd
Stanley Kim WinSanTor
Michael Cole Global Neurohealth Ventures
Ronald Shazer Denovo Biopharma
Ehud Bendory 3NT Medical
Giles Dudley University of Edinburgh - Medical innovations
Anton Neschadim ImmunoBiochem Corporation
david berry MD Leading BioSciences
Andrew Tasker Femeda
James Forte Fairwater Marketing Strategies
Leslie Morgan OBE DL Durbin
Pascal Nigen Alpha Bronze
yoichiro miwa mitsui global investment
Lora Feng Hongjing Capital
Eyal Leibovitz Cellect Biotechnology Ltd.
Shai Yarkoni Cellect Biotechnology Ltd.
Nuriel Chirich Kasbian Cellect Biotechnology Ltd.
Grace Shen Jubilant Pharma
Wei Wu BOE Ventures
Ehud Belder Telesofia Medical
Gerhard Koenig ATLAS Venture
Gabriele Grecchi Silk Biomaterials
Prasun Mishra Agility Pharmaceuticals
Enej Kuscer TM3 Therapeutics
Nathan Hatfield Recursion Pharmaceuticals
Mark Lewis NanoValent Pharmaceuticals Inc.
Lynda PARKER Dohmen Life Science Services
Sam Parlett TL Biolabs
Greg Kading IM Therapeutics
Mark Charest Phenomic Capital
Fei Jin DrugCendR Inc.
Leonide Saad Alkeus Pharmaceuticals
Steven Zimmer EpiCombi Therapeutics ltd
Jeff Jonas Sage Therapeutics
Jeff Jonker NGM Bio
Ivan Fedyunin Millhouse

Become a Supporter

For more information about sponsorship, please email us at sponsorship@biobreak.org.

Web design: GillFishmanDesign.com